PDB Short entry for 3O96 HEADER TRANSFERASE 03-AUG-10 3O96 TITLE CRYSTAL STRUCTURE OF HUMAN AKT1 WITH AN ALLOSTERIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 2-443; COMPND 5 SYNONYM: RAC-PK-ALPHA, PROTEIN KINASE B, PKB, PROTO-ONCOGENE C-AKT; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HI5 INSECT CELLS KEYWDS PLECKSTRIN HOMOLOGY, PROTEIN KINASE, ALLOSTERIC INHIBITOR, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR W.C.VOEGTLI,W.-I.WU,H.A.LORD-ONDASH,F.P.DIZON,G.P.A.VIGERS, AUTHOR 2 B.J.BRANDHUBER REVDAT 2 06-SEP-23 3O96 1 REMARK SEQADV REVDAT 1 13-OCT-10 3O96 0 JRNL AUTH W.I.WU,W.C.VOEGTLI,H.L.STURGIS,F.P.DIZON,G.P.VIGERS, JRNL AUTH 2 B.J.BRANDHUBER JRNL TITL CRYSTAL STRUCTURE OF HUMAN AKT1 WITH AN ALLOSTERIC INHIBITOR JRNL TITL 2 REVEALS A NEW MODE OF KINASE INHIBITION. JRNL REF PLOS ONE V. 5 12913 2010 JRNL REFN ESSN 1932-6203 JRNL PMID 20886116 JRNL DOI 10.1371/JOURNAL.PONE.0012913 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1532264.030 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 11459 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 643 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2520 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2490 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.312 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 643 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0120 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 11459 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1787 REMARK 3 BIN R VALUE (WORKING SET) : 0.3170 REMARK 3 BIN FREE R VALUE : 0.3840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 108 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3031 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 21 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.09000 REMARK 3 B22 (A**2) : 1.00000 REMARK 3 B33 (A**2) : 3.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.52 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.550 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.570 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.690 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.640 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 40.48 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PA REMARK 3 PARAMETER FILE 2 : INH_VIII.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARA REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : INH_VIII.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3O96 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000060822. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC CONFOCAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11462 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.38200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY CODES 1MRV AND 1UNP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM ACETATE-CITRATE BUFFER, 21% PEG REMARK 280 MME 2000, PH 5.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.97000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 ALA A -1 REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 ASP A 46 REMARK 465 GLN A 47 REMARK 465 ARG A 48 REMARK 465 HIS A 89 REMARK 465 VAL A 90 REMARK 465 GLU A 91 REMARK 465 GLU A 114 REMARK 465 GLU A 115 REMARK 465 GLU A 116 REMARK 465 GLU A 117 REMARK 465 MET A 118 REMARK 465 ASP A 119 REMARK 465 PHE A 120 REMARK 465 ARG A 121 REMARK 465 SER A 122 REMARK 465 GLY A 123 REMARK 465 SER A 124 REMARK 465 PRO A 125 REMARK 465 SER A 126 REMARK 465 ASP A 127 REMARK 465 ASN A 128 REMARK 465 SER A 129 REMARK 465 GLY A 130 REMARK 465 ALA A 131 REMARK 465 GLU A 132 REMARK 465 GLU A 133 REMARK 465 MET A 134 REMARK 465 GLU A 135 REMARK 465 VAL A 136 REMARK 465 SER A 137 REMARK 465 LEU A 138 REMARK 465 ALA A 139 REMARK 465 LYS A 140 REMARK 465 PRO A 141 REMARK 465 LYS A 142 REMARK 465 HIS A 143 REMARK 465 ARG A 144 REMARK 465 LYS A 189 REMARK 465 ASP A 190 REMARK 465 GLU A 191 REMARK 465 VAL A 192 REMARK 465 ALA A 193 REMARK 465 HIS A 194 REMARK 465 THR A 195 REMARK 465 LEU A 196 REMARK 465 THR A 197 REMARK 465 GLU A 198 REMARK 465 GLY A 299 REMARK 465 ILE A 300 REMARK 465 LYS A 301 REMARK 465 ASP A 302 REMARK 465 GLY A 303 REMARK 465 ALA A 304 REMARK 465 THR A 305 REMARK 465 MET A 306 REMARK 465 LYS A 307 REMARK 465 THR A 308 REMARK 465 PHE A 309 REMARK 465 CYS A 310 REMARK 465 GLY A 311 REMARK 465 THR A 312 REMARK 465 THR A 430 REMARK 465 SER A 431 REMARK 465 GLU A 432 REMARK 465 THR A 433 REMARK 465 ASP A 434 REMARK 465 THR A 435 REMARK 465 ARG A 436 REMARK 465 TYR A 437 REMARK 465 PHE A 438 REMARK 465 ASP A 439 REMARK 465 GLU A 440 REMARK 465 GLU A 441 REMARK 465 PHE A 442 REMARK 465 THR A 443 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 8 149.46 -176.84 REMARK 500 LYS A 20 44.99 -81.21 REMARK 500 ARG A 41 100.73 -49.16 REMARK 500 GLN A 43 -73.21 -101.12 REMARK 500 VAL A 57 42.64 -98.64 REMARK 500 LEU A 62 -168.39 -104.68 REMARK 500 TRP A 80 -99.69 51.04 REMARK 500 PRO A 93 -8.53 -59.37 REMARK 500 ILE A 186 -86.17 -109.55 REMARK 500 VAL A 201 -14.01 -43.98 REMARK 500 THR A 219 -151.67 -139.83 REMARK 500 ASP A 221 -4.33 -154.08 REMARK 500 PHE A 237 -75.85 -53.15 REMARK 500 ARG A 243 -48.17 75.64 REMARK 500 ARG A 273 -8.96 73.79 REMARK 500 ASP A 283 -168.67 -77.88 REMARK 500 CYS A 296 -93.41 -165.73 REMARK 500 ASP A 398 -120.30 59.29 REMARK 500 LYS A 419 30.13 71.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 148 GLU A 149 130.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IQO A 444 DBREF 3O96 A 2 443 UNP P31749 AKT1_HUMAN 2 443 SEQADV 3O96 GLY A -2 UNP P31749 EXPRESSION TAG SEQADV 3O96 ALA A -1 UNP P31749 EXPRESSION TAG SEQADV 3O96 MET A 0 UNP P31749 EXPRESSION TAG SEQADV 3O96 ALA A 1 UNP P31749 EXPRESSION TAG SEQRES 1 A 446 GLY ALA MET ALA SER ASP VAL ALA ILE VAL LYS GLU GLY SEQRES 2 A 446 TRP LEU HIS LYS ARG GLY GLU TYR ILE LYS THR TRP ARG SEQRES 3 A 446 PRO ARG TYR PHE LEU LEU LYS ASN ASP GLY THR PHE ILE SEQRES 4 A 446 GLY TYR LYS GLU ARG PRO GLN ASP VAL ASP GLN ARG GLU SEQRES 5 A 446 ALA PRO LEU ASN ASN PHE SER VAL ALA GLN CYS GLN LEU SEQRES 6 A 446 MET LYS THR GLU ARG PRO ARG PRO ASN THR PHE ILE ILE SEQRES 7 A 446 ARG CYS LEU GLN TRP THR THR VAL ILE GLU ARG THR PHE SEQRES 8 A 446 HIS VAL GLU THR PRO GLU GLU ARG GLU GLU TRP THR THR SEQRES 9 A 446 ALA ILE GLN THR VAL ALA ASP GLY LEU LYS LYS GLN GLU SEQRES 10 A 446 GLU GLU GLU MET ASP PHE ARG SER GLY SER PRO SER ASP SEQRES 11 A 446 ASN SER GLY ALA GLU GLU MET GLU VAL SER LEU ALA LYS SEQRES 12 A 446 PRO LYS HIS ARG VAL THR MET ASN GLU PHE GLU TYR LEU SEQRES 13 A 446 LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE LEU SEQRES 14 A 446 VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET LYS SEQRES 15 A 446 ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU VAL SEQRES 16 A 446 ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SER SEQRES 17 A 446 ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE GLN SEQRES 18 A 446 THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA ASN SEQRES 19 A 446 GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG VAL SEQRES 20 A 446 PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU ILE SEQRES 21 A 446 VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN VAL SEQRES 22 A 446 VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU ASP SEQRES 23 A 446 LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU CYS SEQRES 24 A 446 LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS THR PHE SEQRES 25 A 446 CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU GLU SEQRES 26 A 446 ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY LEU SEQRES 27 A 446 GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU PRO SEQRES 28 A 446 PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU ILE SEQRES 29 A 446 LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY PRO SEQRES 30 A 446 GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS ASP SEQRES 31 A 446 PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA LYS SEQRES 32 A 446 GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL TRP SEQRES 33 A 446 GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE LYS SEQRES 34 A 446 PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE ASP SEQRES 35 A 446 GLU GLU PHE THR HET IQO A 444 42 HETNAM IQO 1-(1-(4-(7-PHENYL-1H-IMIDAZO[4,5-G]QUINOXALIN-6-YL) HETNAM 2 IQO BENZYL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOL-2(3H)-ONE HETSYN IQO 1-{1-[4-(6-PHENYL-1H-IMIDAZO[4,5-G]QUINOXALIN-7-YL) HETSYN 2 IQO BENZYL]PIPERIDIN-4-YL}-1,3-DIHYDRO-2H-BENZIMIDAZOL-2- HETSYN 3 IQO ONE FORMUL 2 IQO C34 H29 N7 O FORMUL 3 HOH *21(H2 O) HELIX 1 1 LEU A 52 SER A 56 5 5 HELIX 2 2 GLU A 94 GLU A 97 5 4 HELIX 3 3 GLU A 98 LYS A 112 1 15 HELIX 4 4 GLU A 184 ILE A 186 5 3 HELIX 5 5 ARG A 200 ASN A 204 5 5 HELIX 6 6 GLU A 234 ARG A 243 1 10 HELIX 7 7 SER A 246 GLU A 267 1 22 HELIX 8 8 LYS A 276 GLU A 278 5 3 HELIX 9 9 ALA A 317 GLU A 322 1 6 HELIX 10 10 ARG A 328 GLY A 345 1 18 HELIX 11 11 ASP A 353 GLU A 364 1 12 HELIX 12 12 GLY A 373 LEU A 384 1 12 HELIX 13 13 ASP A 398 GLN A 404 1 7 HELIX 14 14 HIS A 405 ALA A 409 5 5 HELIX 15 15 VAL A 412 GLU A 418 1 7 SHEET 1 A 3 ILE A 6 ARG A 15 0 SHEET 2 A 3 TRP A 22 LYS A 30 -1 O ARG A 25 N LEU A 12 SHEET 3 A 3 PHE A 35 TYR A 38 -1 O TYR A 38 N TYR A 26 SHEET 1 B 2 ILE A 74 GLN A 79 0 SHEET 2 B 2 THR A 82 THR A 87 -1 O THR A 82 N GLN A 79 SHEET 1 C 5 PHE A 150 GLY A 159 0 SHEET 2 C 5 GLY A 162 GLU A 169 -1 O GLY A 162 N GLY A 159 SHEET 3 C 5 TYR A 175 LYS A 182 -1 O MET A 178 N ILE A 165 SHEET 4 C 5 ARG A 222 GLU A 228 -1 O LEU A 223 N LEU A 181 SHEET 5 C 5 LEU A 213 GLN A 218 -1 N TYR A 215 O VAL A 226 SHEET 1 D 2 LEU A 280 LEU A 282 0 SHEET 2 D 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SSBOND 1 CYS A 60 CYS A 77 1555 1555 2.95 CISPEP 1 ARG A 67 PRO A 68 0 -6.67 SITE 1 AC1 12 TRP A 80 ILE A 84 SER A 205 LEU A 210 SITE 2 AC1 12 THR A 211 LEU A 264 LYS A 268 TYR A 272 SITE 3 AC1 12 ILE A 290 ASP A 292 CYS A 296 HOH A 455 CRYST1 49.310 69.940 61.850 90.00 100.60 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020280 0.000000 0.003795 0.00000 SCALE2 0.000000 0.014298 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016449 0.00000